Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas.

Endocr Oncol · 2025 · PMC12392752 · PMID 40894955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

We compared the effect of treatment, comparing PRRT versus other types (molecular targeted agents or chemotherapy), and found a difference in median PFS, although this did not reach statistical significance (PRRT versus molecular targeted agents/chemotherapy: median 8 months, 95% CI: 0–25.6 vs 5 months, 95% CI: 4.2–5.9; log-rank P value 0.093, Fig. 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.